# Truist Financial Corp: financial statements, quarterly

TFC · NYSE · CIK 92230 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tfc.md) · [Financials](/companies/tfc/financials.md) · [Filings](/companies/tfc/filings.md) · [Insiders](/companies/tfc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tfc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [2,723 d](/filings/0000092230-24-000010.md) | [2,812](/filings/0000092230-24-000025.md) | [2,824](/filings/0000092230-24-000045.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(56.0) d](/filings/0000092230-26-000030.md) | [232](/filings/0000092230-25-000050.md) | [(1,324)](/filings/0000092230-25-000123.md) | [271](/filings/0000092230-25-000157.md) | [265 d](/filings/0000092230-26-000030.md) | [274](/filings/0000092230-26-000062.md) | [273](/filings/0000092230-26-000099.md) | [285](/filings/0000092230-26-000129.md) | [210 d](/filings/0000092230-26-000030.md) | [209](/filings/0000092230-26-000062.md) | [262](/filings/0000092230-26-000099.md) | [96.0](/filings/0000092230-26-000129.md) |
| Net income | $m | [(5,090) d](/filings/0000092230-26-000030.md) | [1,200](/filings/0000092230-25-000050.md) | [922](/filings/0000092230-25-000123.md) | [1,442](/filings/0000092230-25-000157.md) | [1,276 d](/filings/0000092230-26-000030.md) | [1,261](/filings/0000092230-26-000062.md) | [1,240](/filings/0000092230-26-000099.md) | [1,452](/filings/0000092230-26-000129.md) | [1,354 d](/filings/0000092230-26-000030.md) | [1,481](/filings/0000092230-26-000062.md) | [1,553](/filings/0000092230-26-000099.md) | [799](/filings/0000092230-26-000129.md) |
| Diluted EPS | $ per share | not reported | [0.81](/filings/0000092230-25-000050.md) | [0.62](/filings/0000092230-25-000123.md) | [0.99](/filings/0000092230-25-000157.md) | not reported | [0.87](/filings/0000092230-26-000062.md) | [0.90](/filings/0000092230-26-000099.md) | [1.04](/filings/0000092230-26-000129.md) | not reported | [1.09](/filings/0000092230-26-000062.md) | [1.23](/filings/0000092230-26-000099.md) | [0.56](/filings/0000092230-26-000129.md) |
| Basic EPS | $ per share | not reported | [0.82](/filings/0000092230-25-000050.md) | [0.62](/filings/0000092230-25-000123.md) | [1.00](/filings/0000092230-25-000157.md) | not reported | [0.88](/filings/0000092230-26-000062.md) | [0.91](/filings/0000092230-26-000099.md) | [1.05](/filings/0000092230-26-000129.md) | not reported | [1.10](/filings/0000092230-26-000062.md) | [1.24](/filings/0000092230-26-000099.md) | [0.57](/filings/0000092230-26-000129.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [535](/filings/0000092230-25-000020.md) | [535](/filings/0000092230-24-000025.md) | [520](/filings/0000092230-24-000045.md) | [523](/filings/0000092230-24-000079.md) | [531](/filings/0000092230-26-000030.md) | [536](/filings/0000092230-25-000050.md) | [544](/filings/0000092230-25-000123.md) | [544](/filings/0000092230-25-000157.md) | [548](/filings/0000092230-26-000129.md) | [549](/filings/0000092230-26-000062.md) | [556](/filings/0000092230-26-000099.md) | [554](/filings/0000092230-26-000129.md) |
| Total liabilities | $bn | [476](/filings/0000092230-25-000020.md) | [476](/filings/0000092230-24-000025.md) | [456](/filings/0000092230-24-000045.md) | [458](/filings/0000092230-24-000079.md) | [467](/filings/0000092230-26-000030.md) | [471](/filings/0000092230-25-000050.md) | [479](/filings/0000092230-25-000123.md) | [478](/filings/0000092230-25-000157.md) | [482](/filings/0000092230-26-000129.md) | [485](/filings/0000092230-26-000062.md) | [492](/filings/0000092230-26-000099.md) | [493](/filings/0000092230-26-000129.md) |
| Long-term debt | $bn | [38.9](/filings/0000092230-25-000020.md) | [39.1](/filings/0000092230-24-000025.md) | [34.6](/filings/0000092230-24-000045.md) | [36.8](/filings/0000092230-24-000079.md) | [35.0](/filings/0000092230-26-000030.md) | [32.0](/filings/0000092230-25-000050.md) | [44.4](/filings/0000092230-25-000123.md) | [41.7](/filings/0000092230-25-000157.md) | [42.0](/filings/0000092230-26-000129.md) | [41.6](/filings/0000092230-26-000062.md) | [43.0](/filings/0000092230-26-000099.md) | [53.4](/filings/0000092230-26-000129.md) |
| Short-term borrowings | $bn | [24.8](/filings/0000092230-25-000020.md) | [26.3](/filings/0000092230-24-000025.md) | [22.8](/filings/0000092230-24-000045.md) | [20.9](/filings/0000092230-24-000079.md) | [29.2](/filings/0000092230-26-000030.md) | [23.7](/filings/0000092230-25-000050.md) | [16.6](/filings/0000092230-25-000123.md) | [29.4](/filings/0000092230-25-000157.md) | [27.8](/filings/0000092230-26-000129.md) | [27.4](/filings/0000092230-26-000062.md) | [26.9](/filings/0000092230-26-000099.md) | [12.4](/filings/0000092230-26-000129.md) |
| Shareholders' equity | $bn | [59.3](/filings/0000092230-26-000030.md) | [59.1](/filings/0000092230-25-000123.md) | [63.8](/filings/0000092230-25-000157.md) | [65.7](/filings/0000092230-25-000157.md) | [63.7](/filings/0000092230-26-000030.md) | [64.6](/filings/0000092230-26-000099.md) | [64.8](/filings/0000092230-26-000129.md) | [65.6](/filings/0000092230-26-000129.md) | [65.2](/filings/0000092230-26-000129.md) | [64.2](/filings/0000092230-26-000062.md) | [64.1](/filings/0000092230-26-000099.md) | [61.5](/filings/0000092230-26-000129.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,376 d](/filings/0000092230-26-000030.md) | [(990)](/filings/0000092230-25-000050.md) | [845 d](/filings/0000092230-25-000123.md) | [1,534 d](/filings/0000092230-25-000157.md) | [775 d](/filings/0000092230-26-000030.md) | [746](/filings/0000092230-26-000062.md) | [914 d](/filings/0000092230-26-000099.md) | [1,497 d](/filings/0000092230-26-000129.md) | [2,582 d](/filings/0000092230-26-000030.md) | [679](/filings/0000092230-26-000062.md) | [1,039 d](/filings/0000092230-26-000099.md) | [1,763 d](/filings/0000092230-26-000129.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [693 d](/filings/0000092230-26-000030.md) | [694](/filings/0000092230-25-000050.md) | [696 d](/filings/0000092230-25-000123.md) | [695 d](/filings/0000092230-25-000157.md) | [685 d](/filings/0000092230-26-000030.md) | [679](/filings/0000092230-26-000062.md) | [670 d](/filings/0000092230-26-000099.md) | [665 d](/filings/0000092230-26-000129.md) | [658 d](/filings/0000092230-26-000030.md) | [645](/filings/0000092230-26-000062.md) | [636 d](/filings/0000092230-26-000099.md) | [629 d](/filings/0000092230-26-000129.md) |
| Share repurchases | $m | [0.0 d](/filings/0000092230-26-000030.md) | [0.0](/filings/0000092230-25-000050.md) | [0.0 d](/filings/0000092230-25-000123.md) | [500 d](/filings/0000092230-25-000157.md) | [500 d](/filings/0000092230-26-000030.md) | [500](/filings/0000092230-26-000062.md) | [750 d](/filings/0000092230-26-000099.md) | [500 d](/filings/0000092230-26-000129.md) | [750 d](/filings/0000092230-26-000030.md) | [1,134](/filings/0000092230-26-000062.md) | [1,200 d](/filings/0000092230-26-000099.md) | [1,200 d](/filings/0000092230-26-000129.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,339](/filings/0000092230-24-000025.md) | [1,337](/filings/0000092230-24-000045.md) | [1,341](/filings/0000092230-24-000079.md) | [1,347](/filings/0000092230-25-000050.md) | [1,338](/filings/0000092230-25-000123.md) | [1,349](/filings/0000092230-25-000157.md) | [1,324](/filings/0000092230-26-000062.md) | [1,305](/filings/0000092230-26-000099.md) | [1,297](/filings/0000092230-26-000129.md) | [1,267](/filings/0000092230-26-000062.md) | [1,239](/filings/0000092230-26-000099.md) | [1,226](/filings/0000092230-26-000129.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,198,488,412 at 2026-09-30, from the cover of the [10-Q filed 2026-10-28](/filings/0000092230-26-000129.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 05:19 ET. No prices; not investment advice.